设备检测到的心房高频率发作是中风的风险标志物吗？
Are device-detected atrial high-rate episodes a risk marker for stroke?
作者信息
Hanna Peter, Buch Eric, Shivkumar Kalyanam
机构信息
University of California Los Angeles (UCLA) Cardiac Arrhythmia Center, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Neurocardiology Research Program of Excellence, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
出版信息
Nat Cardiovasc Res. 2023 Dec;2(12):1097-1098. doi: 10.1038/s44161-023-00383-y.
Abstract
Continuous cardiac rhythm monitoring via cardiac implantable electronic devices and other wearable monitors has identified an increased number of patients with asymptomatic atrial fibrillation. However, not all patients with device-detected AHREs are alike, and fine-tuning risk assessment may help identify those patients that benefit the most from anticoagulation.”
摘要
通过心脏植入式电子设备和其他可穿戴监测器进行的连续心律监测发现，无症状房颤患者的数量有所增加。然而，并非所有通过设备检测到房性心律事件（AHREs）的患者都相同，微调风险评估可能有助于识别那些从抗凝治疗中获益最大的患者。
相似文献
1
Are device-detected atrial high-rate episodes a risk marker for stroke?设备检测到的心房高频率发作是中风的风险标志物吗？
Nat Cardiovasc Res. 2023 Dec;2(12):1097-1098. doi: 10.1038/s44161-023-00383-y.
2
Identifying At-Risk Patients for Sustained Atrial High-Rate Episodes Using the CHEST Score: The West Birmingham Atrial Fibrillation Project.利用 CHEST 评分识别持续性心房快速性心律失常的高危患者：西伯明翰心房颤动项目。
J Am Heart Assoc. 2021 Mar 16;10(6):e017519. doi: 10.1161/JAHA.120.017519. Epub 2021 Mar 5.
3
Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence.心房高频事件：患病率、卒中风险、对管理的影响以及证据中的临床空白。
Europace. 2019 Oct 1;21(10):1459-1467. doi: 10.1093/europace/euz172.
4
Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study.长期持续筛查心房颤动后的心力衰竭事件：随机LOOP研究结果
Circ Arrhythm Electrophysiol. 2024 Aug;17(8):e012764. doi: 10.1161/CIRCEP.124.012764. Epub 2024 Jul 18.
5
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.优化房颤易感性和负荷指标，以评估房颤严重程度、风险和结局。
Cardiovasc Res. 2021 Jun 16;117(7):1-21. doi: 10.1093/cvr/cvab147.
6
Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights From Patients at Risk Monitored Long Term With an Implantable Loop Recorder.植入式循环记录仪长期监测的高危患者对心房颤动筛查中节律监测策略的综合评估。
Circulation. 2020 May 12;141(19):1510-1522. doi: 10.1161/CIRCULATIONAHA.119.044407. Epub 2020 Mar 2.
7
Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report.隐源性卒中的心律监测策略：2015年诊断与监测卒中焦点小组报告
J Am Heart Assoc. 2016 Mar 15;5(3):e002944. doi: 10.1161/JAHA.115.002944.
8
Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke.心房颤动检测：中风前后探寻不规则心跳
Stroke. 2017 Oct;48(10):2671-2677. doi: 10.1161/STROKEAHA.117.017083. Epub 2017 Sep 15.
9
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).心房颤动筛查：一份由心律协会（HRS）、亚太心律协会（APHRS）和拉丁美洲心脏刺激与电生理学会（SOLAECE）认可的欧洲心律协会（EHRA）共识文件
Europace. 2017 Oct 1;19(10):1589-1623. doi: 10.1093/europace/eux177.
10
Electrocardiogram-Based Artificial Intelligence to Discriminate Cardioembolic Stroke and Stratify Risk of Atrial Fibrillation After Stroke.基于心电图的人工智能用于鉴别心源性栓塞性卒中及对卒中后房颤风险进行分层
Circ Arrhythm Electrophysiol. 2024 Oct;17(10):e012959. doi: 10.1161/CIRCEP.124.012959. Epub 2024 Aug 28.
本文引用的文献
1
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.在伴有心房快速发作的患者中使用依度沙班进行抗凝治疗。
N Engl J Med. 2023 Sep 28;389(13):1167-1179. doi: 10.1056/NEJMoa2303062. Epub 2023 Aug 25.
2
Severity and Etiology of Incident Stroke in Patients Screened for Atrial Fibrillation vs Usual Care and the Impact of Prior Stroke: A Post Hoc Analysis of the LOOP Randomized Clinical Trial.在接受心房颤动筛查的患者与常规护理相比，事件性中风的严重程度和病因，以及既往中风的影响：LOOP 随机临床试验的事后分析。
JAMA Neurol. 2022 Oct 1;79(10):997-1004. doi: 10.1001/jamaneurol.2022.3031.
3
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.植入式循环记录仪检测心房颤动以预防卒中（LOOP研究）：一项随机对照试验
Lancet. 2021 Oct 23;398(10310):1507-1516. doi: 10.1016/S0140-6736(21)01698-6. Epub 2021 Aug 29.
4
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial.系统筛查心房颤动（STROKESTOP）的临床结局：一项多中心、平行组、非盲、随机对照试验。
Lancet. 2021 Oct 23;398(10310):1498-1506. doi: 10.1016/S0140-6736(21)01637-8. Epub 2021 Aug 29.
5
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.心房颤动筛查：AF-SCREEN 国际合作研究报告。
Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693.
6
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.ASSERT 中设备检测到的无症状性心房颤动持续时间与卒中发生情况。
Eur Heart J. 2017 May 1;38(17):1339-1344. doi: 10.1093/eurheartj/ehx042.
7
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.评估 182678 例心房颤动患者缺血性卒中和出血的风险分层方案：瑞典心房颤动队列研究。
Eur Heart J. 2012 Jun;33(12):1500-10. doi: 10.1093/eurheartj/ehr488. Epub 2012 Jan 13.
8
Subclinical atrial fibrillation and the risk of stroke.无症状性心房颤动与卒中风险。
N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575.
9
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.采用新型基于风险因素的方法对房颤患者的卒中与血栓栓塞风险进行临床分层的研究：房颤的欧洲心脏调查。
Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.
10
Antithrombotic therapy in atrial fibrillation: a review of randomized trials with special reference to the Stroke Prevention in Atrial Fibrillation II (SPAF II) Trial.心房颤动的抗栓治疗：对随机试验的综述，特别参考心房颤动卒中预防II（SPAF II）试验
Prog Cardiovasc Dis. 1996 Jan-Feb;38(4):337-42. doi: 10.1016/s0033-0620(96)80018-1.
Zotero 插件